Seasonality of respiratory syncytial virus and its association with meteorological factors in 13 European countries, week 40 2010 to week 39 2019
- PMID: 35451364
- PMCID: PMC9027150
- DOI: 10.2807/1560-7917.ES.2022.27.16.2100619
Seasonality of respiratory syncytial virus and its association with meteorological factors in 13 European countries, week 40 2010 to week 39 2019
Abstract
BackgroundRespiratory syncytial virus (RSV) is the predominant cause of clinical pneumonia among infants and young children, often peaking during the winter months in temperate regions.AimTo describe RSV seasonality in 13 European countries and examine its association with meteorological factors.MethodsWe included weekly RSV seasonality data from 13 European countries between week 40 2010 and week 39 2019. Using local weighted regression method, we modelled weekly RSV activity with meteorological factors using data from the 2010/11 to the 2017/18 season. We predicted the weekly RSV activity of the 2018/19 season across 41 European countries and validated our prediction using empirical data.ResultsAll countries had annual wintertime RSV seasons with a longitudinal gradient in RSV onset (Pearson's correlation coefficient, r = 0.71, 95% CI: 0.60 to 0.80). The RSV season started 3.8 weeks later (95% CI: -0.5 to 8.0) in countries in the eastern vs western parts of Europe, and the duration ranged from 8-18 weeks across seasons and countries. Lower temperature and higher relative humidity were associated with higher RSV activity, with a 14-day lag time. Through external validation, the prediction error in RSV season onset was -2.4 ± 3.2 weeks. Similar longitudinal gradients in RSV onset were predicted by our model for the 2018/19 season (r = 0.45, 95% CI: 0.16 to 0.66).ConclusionMeteorological factors, such as temperature and relative humidity, could be used for early warning of RSV season onset. Our findings may inform healthcare services planning and optimisation of RSV immunisation strategies in Europe.
Keywords: Europe; Respiratory syncytial virus; humidity; seasonality; temperature.
Conflict of interest statement
Figures




References
-
- Shi T, McAllister DA, O’Brien KL, Simoes EAF, Madhi SA, Gessner BD, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017;390(10098):946-58. 10.1016/S0140-6736(17)30938-8 - DOI - PMC - PubMed
-
- Shi T, Denouel A, Tietjen AK, Campbell I, Moran E, Li X, et al. Global Disease burden estimates of respiratory syncytial virus–associated acute respiratory infection in older adults in 2015: a systematic review and meta-analysis. J Infect Dis. 2020;222(Suppl 7):S577-83. 10.1093/infdis/jiz059 - DOI - PubMed
-
- Reeves RM, van Wijhe M, Tong S, Lehtonen T, Stona L, Teirlinck AC, et al. Respiratory syncytial virus-associated hospital admissions in children younger than 5 years in 7 European countries using routinely collected datasets. J Infect Dis. 2020;222(Suppl 7):S599-605. 10.1093/infdis/jiaa360 - DOI - PubMed
-
- Teale A, Deshpande S, Burls A. Palivizumab and the importance of cost effectiveness. BMJ. 2009;338:b1935. 10.1136/bmj.b1935 - DOI
-
- PATH. RSV Vaccine and mAb Snapshot. 2020. Available from: https://www.path.org/resources/rsv-vaccine-and-mab-snapshot
MeSH terms
LinkOut - more resources
Full Text Sources
Medical